110 related articles for article (PubMed ID: 11464498)
1. [Our experience regarding biologically inactive gastroenteropancreatic neuroendocrine tumors].
Napolitano L; Francomano F; Gargano E; Francione T; Angelucci D; Napolitano AM
Ann Ital Chir; 2001; 72(1):61-4; discussion 65. PubMed ID: 11464498
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: Defining selection criteria to improve survival.
van Vilsteren FG; Baskin-Bey ES; Nagorney DM; Sanderson SO; Kremers WK; Rosen CB; Gores GJ; Hobday TJ
Liver Transpl; 2006 Mar; 12(3):448-56. PubMed ID: 16498656
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms.
Attili F; Capurso G; Vanella G; Fuccio L; Delle Fave G; Costamagna G; Larghi A
Dig Liver Dis; 2014 Jan; 46(1):9-17. PubMed ID: 23731843
[TBL] [Abstract][Full Text] [Related]
4. A rare case with synchronous gastric gastrointestinal stromal tumor, pancreatic neuroendocrine tumor, and uterine leiomyoma.
Arabadzhieva E; Yonkov A; Bonev S; Bulanov D; Taneva I; Vlahova A; Dikov T; Dimitrova V
World J Surg Oncol; 2016 Nov; 14(1):287. PubMed ID: 27846844
[TBL] [Abstract][Full Text] [Related]
5. Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau disease.
Corleto VD; Cotesta D; Petramala L; Panzuto F; Pagnini C; Masoni L; Verrienti A; Delle Fave G; Filetti S; Letizia C
JOP; 2009 Sep; 10(5):562-5. PubMed ID: 19734639
[TBL] [Abstract][Full Text] [Related]
6. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
7. [Surgical treatments for gastroenteropancreatic neuroendocrine tumor (GEP-NET)].
Aoki T; Kokudo N
Nihon Shokakibyo Gakkai Zasshi; 2014 Dec; 111(12):2272-9. PubMed ID: 25482902
[No Abstract] [Full Text] [Related]
8. New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.
Phan AT; Kunz PL; Reidy-Lagunes DL
Clin Adv Hematol Oncol; 2015 May; 13(5 Suppl 5):1-18; quiz 1 p following 18. PubMed ID: 26430956
[TBL] [Abstract][Full Text] [Related]
9. Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute.
Shin Y; Ha SY; Hyeon J; Lee B; Lee J; Jang KT; Kim KM; Park YS; Park CK
Cancer Res Treat; 2015 Oct; 47(4):738-46. PubMed ID: 25687852
[TBL] [Abstract][Full Text] [Related]
10. Staged hepatectomy and whipple procedure in metastatic gastroenteropancreatic endocrine carcinoma: report of a case.
Marchesi F; Sarli L; Violi V; Roncoroni L
Int Surg; 2006; 91(5):247-50. PubMed ID: 17061667
[TBL] [Abstract][Full Text] [Related]
11. GEP-NETS update: a review on surgery of gastro-entero-pancreatic neuroendocrine tumors.
Partelli S; Maurizi A; Tamburrino D; Baldoni A; Polenta V; Crippa S; Falconi M
Eur J Endocrinol; 2014 Oct; 171(4):R153-62. PubMed ID: 24920289
[TBL] [Abstract][Full Text] [Related]
12. [Neuroendocrine tumors of the gastroenteropancreatic system--reevaluation using the Capella classification].
Brüwer M; Pahlov-Nejad T; Herbst H; Senninger N; Schürmann G
Zentralbl Chir; 2003 Aug; 128(8):656-62. PubMed ID: 12931261
[TBL] [Abstract][Full Text] [Related]
13. Gastroenteropancreatic neuroendocrine tumors: Role of surgery.
Sauvanet A
Ann Endocrinol (Paris); 2019 Jun; 80(3):175-181. PubMed ID: 31079831
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of neuroendocrine tumors.
Tamburrino D; Spoletini G; Partelli S; Muffatti F; Adamenko O; Crippa S; Falconi M
Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):93-102. PubMed ID: 26971846
[TBL] [Abstract][Full Text] [Related]
15. Cocoon formation in patients with midgut neuroendocrine tumors: a rare and unrecognized final pathway.
Wang YZ; King H; Diebold A
Pancreas; 2013 Aug; 42(6):944-8. PubMed ID: 23587852
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathologic characteristics of 127 cases of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) studied in an oncology hospital].
Alvarado-Cabrero I; de Anda-González J; Hernández-Hernández B; Mantilla-Morales A; Valencia-Cedillo R; Medrano-Guzmán R
Rev Gastroenterol Mex; 2012; 77(4):174-80. PubMed ID: 23142406
[TBL] [Abstract][Full Text] [Related]
17. Hypokalemic rhabdomyolysis without watery diarrhea: an unexpected presentation of a pancreatic neuro-endocrine tumor.
Rossi V; Saibeni S; Sinigaglia L; Peracchi M; Parafioriti A; Vecchi M
Am J Gastroenterol; 2006 Mar; 101(3):669-72. PubMed ID: 16464230
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 expression in gastroenteropancreatic neuroendocrine tumors.
Ince AT; Ovünç O; Celikel CA; Göksel S; Tosun S; Peker O
Hepatogastroenterology; 2007 Jun; 54(76):1125-9. PubMed ID: 17629053
[TBL] [Abstract][Full Text] [Related]
19. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: pre- and perioperative therapy in patients with neuroendocrine tumors.
Akerström G; Falconi M; Kianmanesh R; Ruszniewski P; Plöckinger U; ;
Neuroendocrinology; 2009; 90(2):203-8. PubMed ID: 19713712
[No Abstract] [Full Text] [Related]
20. Aggressive gastro-entero-pancreatic neoplasms.
Coriat R
Ann Endocrinol (Paris); 2019 Jun; 80(3):185-186. PubMed ID: 31064660
[No Abstract] [Full Text] [Related]
[Next] [New Search]
